Exact Mass: 716.2777983999999
Exact Mass Matches: 716.2777983999999
Found 79 metabolites which its exact mass value is equals to given mass value 716.2777983999999,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Mulberrofuran T
Mulberrofuran T is found in fruits. Mulberrofuran T is a constituent of Morus alba (white mulberry)
Bn-NCC-1
Bn-NCC-1 is found in brassicas. Bn-NCC-1 is isolated from rape cotyledons. Isolated from rape cotyledons. Bn-NCC-1 is found in brassicas.
Manassantin B
6-O-alpha-L-(3-O-,4-O-dibenzoyl)rhamnopyranosylcatalpol|6-O-??-L-(3-O-,4-O-Dibenzoyl)rhamnopyranosylcatalpol|gmelinoside K
Tasumatrol L
Trisulfate-(2beta,3alpha,6alpha,24?鈥?-24,25,26,26-Tetramethylcholestane-2,3,6-triol
6-O-??-L-(2-O-,3-O-Dibenzoyl)rhamnopyranosylcatalpol
Me glycoside,tetrabenzyl-3-O-alpha-D-Mannopyranosyl-D-mannose
14-deoxo-3-O-propionyl-5,15-di-O-acetyl-7-O-nicotinoyl-myrsinol-14beta-nicotinoate|14-desoxo-3-O-propionyl-5,15-di-O-acetyl-7-O-nicotinoyl-myrsinol-14beta-nicotinoate
C39H44N2O11 (716.2944954000001)
Me glycoside 2,3,4,4-tetrabenzyl-6-O-alpha-D-Mannopyranosyl-D-mannose
6-O-??-L-(2-O-,4-O-Dibenzoyl)rhamnopyranosylcatalpol
Trp Trp Tyr Tyr
C40H40N6O7 (716.2958330000001)
Trp Tyr Trp Tyr
C40H40N6O7 (716.2958330000001)
Trp Tyr Tyr Trp
C40H40N6O7 (716.2958330000001)
Tyr Trp Trp Tyr
C40H40N6O7 (716.2958330000001)
Tyr Trp Tyr Trp
C40H40N6O7 (716.2958330000001)
Tyr Tyr Trp Trp
C40H40N6O7 (716.2958330000001)
Mulberrofuran T
Bn-NCC-1
3-[(2R,5S)-5-(4-Fluorophenyl)-2-[(S)-[(4-fluorophenyl(aMino)]][4-[triMethylsilyl]-oxy]phenyl]Methyl]-1-oxo-5-[(triMethylsily)-oxy]pentyl]-4-phenyl-(4S)-2-oxazolidinone
C39H46F2N2O5Si2 (716.2913169999999)
2,6-di([1-(tert-butyl)-1,1-diphenylsilyl]oxy)-9,10-dihydroanthracene-9,10-dione
C46H44O4Si2 (716.2777983999999)
4,4-((1E,1E)-ANTHRACENE-9,10-DIYLBIS(ETHENE-2,1-DIYL))BIS(N,N-DIPHENYLANILINE)
benzene-1,3-dicarboxylic acid,2,2-dimethylpropane-1,3-diol,2-ethyl-2-(hydroxymethyl)propane-1,3-diol,hexanedioic acid,terephthalic acid
1,2-Bis((2S,5S)-2,5-diisopropylphospholano)benzene(cyclooctadiene)rhodium(I) tetrafluoroborate
Mitratapide
C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent
DICHORO(3-METHYL-2-BUTENYLIDENE)BIS
C35H62Cl2P2Ru (716.2746972000001)
(+)-1,2-BIS((2R,5R)-2,5-DI-I-PROPYLPHOSPHOLANO)BENZENE)1,5-CYCLOOCTADIENE)RHODIUM (I) TETRAFLUOROBORATE
manassantin B
Manassantin B is a lignan isolated from Saururus cernuus and Saururus chinensis and has been shown to exhibit antineoplastic activity. It has a role as a metabolite and an antineoplastic agent. It is a dimethoxybenzene, a member of benzodioxoles, a lignan, a member of oxolanes and a secondary alcohol. Manassantin B is a natural coumarin derivative that has been identified for its various biological functions, particularly in the context of cancer research and antiviral therapy. Its key biological roles include: Antitumor Activity: Manassantin B has shown potential in inhibiting the growth of cancer cells. It may interfere with signaling pathways that are crucial for tumor cell proliferation and survival, although the exact mechanisms are still under investigation. Antiviral Properties: This compound has demonstrated effectiveness against certain viruses, possibly by inhibiting viral replication or modulating the host’s immune response to the infection. Manassantin B could help in starving tumors of their blood supply. Modulation of Apoptosis: It may induce apoptosis, which is programmed cell death, in cancer cells. This is a mechanism by which the body eliminates unwanted or damaged cells, including cancerous ones. Inhibition of Kinases: Some studies suggest that Manassantin B can inhibit kinases, which are enzymes that play a role in cell signaling and are often overactive in cancer. It’s important to note that while Manassantin B shows promise in laboratory settings, its efficacy and safety in clinical settings are still being researched. The compound’s precise mechanisms of action and its potential as a therapeutic agent require further investigation.
alpha-Neup5,9Ac2-(2->6)-beta-D-Galp-(1->3)-beta-D-GlcpNAc
alpha-Neup5,9Ac2-(2->6)-beta-D-Galp-(1->4)-beta-D-GlcpNAc
alpha-L-Fucp-(1->3)-beta-D-GalpNAc-(1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc
N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-L-fucopyranosyl-(1->2)-alpha-L-fucopyranosyl-(1->3)]-N-acetyl-beta-D-glucosamine
N-acetyl-beta-D-glucosaminyl-(1->4)-[alpha-L-fucosyl-(1->3)]-[alpha-L-fucosyl-(1->6)]-N-acetyl-beta-D-glucosamine
Pan-RAS-IN-1
Pan-RAS-IN-1 is a pan-Ras inhibitor that disrupts the interaction of Ras proteins and their effectors.
2-[3-hydroxy-3-(4-hydroxy-3-methoxyphenyl)-2-{4-[4-(4-hydroxy-3-methoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2-methoxyphenoxy}propoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
5-(benzoyloxy)-4-hydroxy-2-{[2-(hydroxymethyl)-10-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,9-dioxatricyclo[4.4.0.0²,⁴]dec-7-en-5-yl]oxy}-6-methyloxan-3-yl benzoate
n-(1-carbamimidoyl-2-hydroxypiperidin-3-yl)-1-[2-({3-[3-chloro-4-(sulfooxy)phenyl]-1,2-dihydroxypropylidene}amino)-4-methylpentanoyl]-6-hydroxy-octahydroindole-2-carboximidic acid
C30H45ClN6O10S (716.2606260000001)
(2s,3r,4r,5r,6s)-5-(benzoyloxy)-4-hydroxy-2-{[(1s,2s,4s,5s,6r,10s)-2-(hydroxymethyl)-10-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,9-dioxatricyclo[4.4.0.0²,⁴]dec-7-en-5-yl]oxy}-6-methyloxan-3-yl benzoate
(1s,2r,4r,5r,6s,8r,10s,11s,12r,14r,15s,19r,20r,21s)-4,20,21-tris(acetyloxy)-6-(furan-3-yl)-12,19-dihydroxy-5,11,15-trimethyl-3-oxo-9,17-dioxahexacyclo[13.3.3.0¹,¹⁴.0²,¹¹.0⁵,¹⁰.0⁸,¹⁰]henicosan-16-yl 2-methylbutanoate
(2s,3as,6r,7as)-n-[(2s)-5-carbamimidamido-1-oxopentan-2-yl]-1-[(2r)-2-{[(2r)-3-[3-chloro-4-(sulfooxy)phenyl]-1,2-dihydroxypropylidene]amino}-4-methylpentanoyl]-6-hydroxy-octahydroindole-2-carboximidic acid
C30H45ClN6O10S (716.2606260000001)
(6r,7r,8s,16s,17r,18r)-7,17-diethenyl-8,18-bis({[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy})-3,9,13,19-tetraoxatricyclo[14.4.0.0⁶,¹¹]icosa-1(20),10-diene-2,12-dione
(1r,2s)-2-{4-[(2r,3r,4r,5r)-5-(4-{[(1r,2r)-1-(2h-1,3-benzodioxol-5-yl)-1-hydroxypropan-2-yl]oxy}-3-methoxyphenyl)-3,4-dimethyloxolan-2-yl]-2-methoxyphenoxy}-1-(3,4-dimethoxyphenyl)propan-1-ol
methyl (2s)-2-hydroxy-2-[(1r,3r,4r,5r,10s,12r,14r,15r,16s,18s,19r,20s,22r)-3,15,22-tris(acetyloxy)-5-(furan-3-yl)-16-hydroxy-4,12,18,20-tetramethyl-7-oxo-6,11,13,21-tetraoxaheptacyclo[10.8.1.1¹⁵,¹⁸.0¹,¹⁰.0⁴,⁹.0¹⁰,¹⁴.0¹⁶,²⁰]docos-8-en-19-yl]acetate
2,7-bis(acetyloxy)-5,9-dimethyl-11-(prop-1-en-2-yl)-4-(propanoyloxy)-8-(pyridine-3-carbonyloxy)-16-oxatetracyclo[7.5.2.0¹,¹⁰.0³,⁷]hexadec-12-en-14-yl pyridine-3-carboxylate
C39H44N2O11 (716.2944954000001)
(1s,2s,3s,3as,4r,9r,10r,13s,13as)-3a,4,9,10,11-pentakis(acetyloxy)-3,13-dihydroxy-2,5,8,8,12-pentamethyl-1h,2h,3h,4h,7h,9h,10h,13h,13ah-cyclopenta[12]annulen-1-yl benzoate
methyl 5-[9-hydroxy-10-(methoxycarbonyl)-8,17-diazahexacyclo[11.6.1.1¹⁰,¹³.0¹,⁹.0²,⁷.0¹⁷,²⁰]henicosa-2,4,6,14-tetraen-8-yl]-20-oxo-19-oxa-8,16-diazahexacyclo[8.8.2.2⁹,¹².0¹,⁹.0²,⁷.0¹²,¹⁶]docosa-2,4,6,13-tetraene-8-carboxylate
C42H44N4O7 (716.3209833999999)